Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canopy Growth is a leading diversified cannabis and cannabinoid-based consumer product company. While primarily known for its recreational cannabis brands, the company operates a significant medical division focused on the research and development of cannabinoid-based pharmaceutical products. Through its clinical research programs, Canopy Growth investigates the therapeutic potential of compounds like THC and CBD for indications including chronic pain, anxiety, and sleep disorders. The company maintains a global presence with production and distribution capabilities across North America, Europe, and other international markets. Its business model integrates large-scale cultivation, advanced extraction technologies, and a robust portfolio of medical and wellness brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canopy Holdings.